AI Generated Image
FDA recalls levothyroxine sodium tablets. Here’s what to know
NBC 7 San Diego • • business
Key Points:
- The FDA has issued a recall for levothyroxine sodium tablets, a commonly prescribed medication for hypothyroidism and reducing enlarged thyroid glands.
- The recalled tablets were found to be "subpotent," containing less active ingredient than required, resulting in decreased effectiveness.
- Major Pharmaceuticals packaged and distributed the recalled tablets, with Cardinal Health also distributing some affected products.
- The recall covers twelve different dosages and packaging from both companies, distributed nationwide, though the FDA did not disclose the total quantity of recalled tablets.
